^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    AidaBreast™

    Company:
    PreludeDx
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    AidaBreast™ will provide personalized testing to the larger Stage I and IIA breast cancer market. AidaBreast™ is powered by a multi-omic platform utilizing proteomic and genomic analyses, and offers a unique, differentiated approach to determine individual patient risk profiles. The first test in the AidaBreast™ portfolio will be for the assessment of radiation therapy benefit.
    Cancer:
    Breast Cancer
    Method:
    Multi-omic platform